Key result
Transcatheter aortic valve implantation resulted in similar 30-day mortality compared to surgical valve replacement in high-risk patients with severe aortic stenosis.
Why the study?
Does transcatheter aortic valve implantation improve 30-day mortality and major adverse events compared to surgical valve replacement in high-risk patients with severe aortic stenosis?
Cohort (n=350)
Does transcatheter aortic valve implantation improve 30-day mortality and major adverse events compared to surgical valve replacement in high-risk patients with severe aortic stenosis?
In high-risk patients with severe aortic stenosis, TAVI offers comparable 30-day mortality to surgical valve replacement but significantly reduces the need for post-procedural dialysis and ICU length of stay.
Answers are grounded in this paper and cite their sources.
TAVI may be viable in high-risk aortic stenosis; leaves open need for randomized trials before practice change.
BACKGROUND: Transcatheter aortic valve implantation (TAVI) has become a therapeutic alternative to surgery for the treatment of severe aortic stenosis in high-surgical risk patients. The aim of this study was to compare 30-day mortality of high-risk patients treated by TAVI versus surgical aortic valve replacement. METHODS: A total of 175 patients (60 men; mean age, 80±6 years; Euroscore 21±13%) having undergone TAVI were compared with 175 matched patients (76 men; mean age, 79±3 years; Euroscore 17±9%), which have undergone conventional aortic valve replacement and were deemed to be high-risk patients by the cardiothoracic surgeons. Thirty-day mortality and major adverse events were recorded in both groups. Patients' characteristics were analyzed for predictors of mortality in the TAVI group. RESULTS: Twenty-one patients (12%) in the TAVI group and 13 patients (8%) in the surgical group died within 30 days of the procedure (P=0.165). Two patients (1%) in the TAVI group and one patient (0.5%) in the conventional surgery group had a major stroke (P=1.0). Seven patients (4%) in the TAVI group and 25 patients (14%) in the conventional surgery group required dialysis post procedure (P=0.0013). The average length of stay in the intensive care unit was lower in the TAVI group compared with the conventional surgical group (3.3±3.1 vs. 6.6±10.5 days; P<0.001). Age was the only independent predictor of mortality in the TAVI group (odds ratio=1.009; 95% confidence interval: 1.001-1.018 per additional year; P=0.0186) and in the total study population (odds ratio=1.007; 95% confidence interval: 1.001-1.013 per additional year; P=0.0186). CONCLUSION: In high-surgical risk patients, TAVI can be performed at a mortality risk comparable with conventional surgery with a reduced length of post interventional intensive care unit stay and less need for dialysis.
No takes yet. Share an insight, caveat, or question.
Stöhr et al. (2011) conducted a cohort in severe aortic stenosis (n=350). Transcatheter aortic valve implantation (TAVI) vs. Surgical aortic valve replacement was evaluated on 30-day mortality (p=0.165). Transcatheter aortic valve implantation resulted in similar 30-day mortality compared to surgical valve replacement in high-risk patients with severe aortic stenosis.
Synapse has enriched 10 related papers. Consider them for comparative context: